Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
Publication in refereed journal

Times Cited
Web of Science100WOS source URL (as at 22/11/2020) Click here for the latest count
Altmetrics Information

Other information
AbstractBackground and objective The off-treatment durability of nucleos(t)ide analogue therapy in Asian hepatitis B e antigen (HBeAg) negative chronic hepatitis B (CHB) and the role of hepatitis B surface antigen (HBsAg) levels in predicting off-treatment durability has not been well investigated.
All Author(s) ListSeto WK, Hui AJ, Wong VWS, Wong GLH, Liu KSH, Lai CL, Yuen MF, Chan HLY
Journal nameGut
Volume Number64
Issue Number4
PublisherBMJ Publishing Group
Pages667 - 672
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesGastroenterology & Hepatology

Last updated on 2020-23-11 at 00:22